MyFinsight
Home
Blog
About
Contact
Download
Download image
Exercise of stock options
$12,173K
Maturities of marketable
securities
$108,879K
Sales of marketable
securities
$3,966K
Net cash provided by
financing activities
$12,173K
Net cash provided by
investing activities
$2,433K
Canceled cashflow
$110,412K
Net change in cash
and cash...
-$27,937K
Canceled cashflow
$14,606K
Stock-based compensation
$8,715K
Prepaid expenses and
other assets
-$3,045K
Accounts payable
$1,446K
Accrued other expenses
and other...
$635K
Depreciation
$537K
Amortization of right-of-use
asset
$53K
Purchases of marketable
securities
$110,152K
Purchases of property and
equipment
$260K
Net cash used in
operating activities
-$42,543K
Canceled cashflow
$14,431K
Net loss
-$49,013K
Accrued compensation
-$6,752K
Accretion of discount on
marketable securities, net
$1,013K
Lease liability
-$196K
Back
Back
Cash Flow
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)
source: myfinsight.com